Impact of physician preferences for homeopathic or conventional medicines on patients with musculoskeletal disorders: Results from the EPI3-MSD cohort

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 10, 2012, Pages 1093-1101

  Rossignol, Michel ^a,b   Begaud, Bernard ^c   Engel, Pierre ^d   Avouac, Bernard ^e   Lert, France ^e   Rouillon, Frederic ^f   Bénichou, Jacques ^g,h   Massol, Jacques ⁱ   Duru, Gerard ^j   Magnier, Anne Marie ^k   Guillemot, Didier ^l,m   Grimaldi Bensouda, Lamiae ^d,n   Abenhaim, Lucien ^o,p  

^a MCGILL UNIVERSITY   (Canada)

^b LA SER Centre for Risk Research   (Canada)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d LA SER   (France)

^e CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^f CENTRE HOSPITALIER SAINTE ANNE   (France)

^g INSERM U657   (France)

^h ROUEN UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^j CYKLAD GROUP   (France)

^k SORBONNE UNIVERSITÉ   (France)

^l INSTITUT PASTEUR   (France)

^m University of Paris Ile de France Ouest   (France)

ⁿ Pharmacoepidemiology and Infectious Diseases (B2PHI)   (France)

^o LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^p London School of Hygiene Tropical Medicine   (United Kingdom)

more..

Author keywords

Cohort; Exposure to NSAID; Homeopathy; Musculoskeletal disease; Pharmacoepidemiology

Indexed keywords

ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ALLOPATHY; ARTICLE; COMORBIDITY; DRUG USE; FEMALE; GENERAL PRACTITIONER; HOMEOPATHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; OBSERVATIONAL STUDY; PHYSICIAN ATTITUDE; PHYSICIAN PREFERENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROPENSITY SCORE; TELECONSULTATION; THERAPY EFFECT;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; DELIVERY OF HEALTH CARE; FAMILY PRACTICE; FEMALE; FRANCE; HISTORY, 21ST CENTURY; HUMANS; LONGITUDINAL STUDIES; MALE; MATERIA MEDICA; MIDDLE AGED; MUSCULOSKELETAL DISEASES; PHYSICIANS; PRIMARY HEALTH CARE; QUESTIONNAIRES;

EID: 84867141000     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3316     Document Type: Article

References (35)

1. Boon HS, Cherkin DC, Erro J, et al. Practice patterns of naturopathic physicians: results from a random survey of licensed practitioners in two US States. BMC Complement Altern Med 2004; 4: 14. DOI: 10.1186/1472-6882-4-14
2. Cherkin DC, Deyo RA, Sherman KJ, et al. Characteristics of visits to licensed acupuncturists, chiropractors, massage therapists, and naturopathic physicians. J Am Board Fam Pract 2002; 15: 463-472.
3. Fleming S, Rabago DP, Mundt MP, Fleming MF. CAM therapies among primary care patients using opioid therapy for chronic pain. BMC Complement Altern Med 2007; 7: 15. DOI: 10.1186/1472-6882-7-15
4. Steinsbekk A, Adams J, Sibbritt D, Jacobsen G, Johnsen R. The profiles of adults who consult alternative health practitioners and/or general practitioners. Scand J Prim Health Care 2007; 25: 86-92. DOI: 10.1080/02813430701267439
5. Grimaldi-Bensouda L, Begaud B, Lert F, et al. Benchmarking the burden of 100 diseases: results of a nationwide representative survey within general practices. Br Med J Open 2011; 1(2):e000215. DOI: 10.1136/bmjopen-2011-000215
6. Rossignol M, Bégaud B, Avouac B, et al. Who seeks primary care for musculoskeletal disorders (MSDs) with physicians prescribing homeopathic and other complementary medicine? Results from the EPI3-LASER survey in France. BMC Musculoskelet Disord 2011; 12: 21. DOI: 10.1186/1471-2474-12-21
7. Dionne CE, Dunn KM, Croft PR, et al. A consensus approach toward the standardization of back pain definitions for use in prevalence studies. Spine 2008; 33: 95-103. DOI: 10.1097/BRS.0b013e31815e7f94
8. Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1171-1178. DOI: 10.1016/S0895-4356(98)00109-7
9. Coste J, Le Parc JM, Berge E, Delecoeuillerie G, Paolaggi JB. French validation of a disability rating scale for the evaluation of low back pain (EIFEL questionnaire). Rev Rhum Ed Fr 1993; 60: 335-341.
10. Beaton DE, Wright JG, Katz JN; Upper Extremity Collaborative Group. Upper Extremity Collaborative Group. Development of the QuickDASH: comparison of three item-reduction approaches. J Bone Joint Surg Am 2005; 87: 1038-1046. DOI: 10.2106/JBJS.D.02060
11. Lequesne MG, Méry C, Samson M, Marty M. Comparison between the WOMAC and the Lequesne indices in patients with knee and hip osteoarthritis. Osteoarthritis Cartilage 1998; 6: 441-442.
12. Grimaldi-Bensouda L, Rossignol M, Aubrun E, El Kerri N, Benichou J, Abenhaim L, PGRx Study Group. Agreement between patients' self-report and physicians' prescriptions on cardiovascular drug exposure: the PGRx database experience. Pharmacoepidemiol Drug Saf 2010; 19: 591-595. DOI: 10.1002/pds.1952
13. Maughan EF, Lewis JS. Outcome measures in chronic low back pain. Eur Spine J 2010; 19: 1484-1494. DOI: 10.1007/s00586-010-1353-6
14. Institut de recherche et documentation en économie de la santé (IRDES). Démographie des médecins. IRDES: Paris, France, 2008.
15. Sevar R. Audit of outcome in 455 consecutive patients treated with homeopathic medicines. Homeopathy 2005; 94: 215-221. DOI:10.1016/j.homp.2005.07.002
16. Brien S, Lachance L, Prescott P, et al. Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial. Rheumatology (Oxford) 2011; 50: 1070-1082. DOI: 10.1093/rheumatology/keq234
17. Chatfield K, Mathie RT, Fisher P. Comment 2 on: Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial. Rheumatology (Oxford) 2011; 50: 1529-1531. DOI: 10.1093/rheumatology/ker120
18. Herman CJ, Dente JM, Allen P, Hunt WC. Ethnic differences in the use of complementary and alternative therapies among adults with osteoarthritis. Prev Chronic Dis 2006; 3(3): A80.
19. Kikuchi M, Matsuura K, Matsumoto Y, Inagaki T, Ueda R. Bibliographical investigation of complementary alternative medicines for osteoarthritis and rheumatoid arthritis. Geriatr Gerontol Int 2009; 9: 29-40. DOI: 10.1111/j.1447-0594.2008.00503.x
20. Rossignol M, Rozenberg S, Leclerc A. Epidemiology of low back pain: what's new? Joint Bone Spine 2009; 76: 608-613. DOI: 10.1016/j.jbspin.2009.07.003
21. Poitras S, Rossignol M, Dionne C, et al. An interdisciplinary clinical practice model for the management of low-back pain in primary care: the CLIP project. BMC Musculoskelet Disord 2008; 9: 54. DOI: 10.1186/1471-2474-9-54
22. Poitras S, Avouac J, Rossignol M, et al. A critical appraisal of guidelines for the management of knee osteoarthritis using Appraisal of Guidelines Research and Evaluation criteria. Arthritis Res Ther 2007; 9: R126. DOI: 10.1186/ar2339
23. Brookhart MA, Wang PS, Solomon DH, Schneeweiss S. Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology 2006; 17: 268-275. DOI: 10.1097/01.ede.0000193606.58671.c5
24. Ionescu-Ittu R, Delaney JA, Abrahamowicz M. Bias-variance trade-off in pharmacoepidemiological studies using physician-preference-based instrumental variables: a simulation study. Pharmacoepidemiol Drug Saf 2009; 18: 562-571. DOI: 10.1002/pds.1757
25. Rassen JA, Brookhart MA, Glynn RJ, Mittleman MA, Schneeweiss S. Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. J Clin Epidemiol 2009; 62: 1233-1241. DOI: 10.1016/j.jclinepi.2008.12.006
26. Brookhart MA, Schneeweiss S. Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results. Int J Biostat 2007; 3: 14.
27. Brookhart MA, Rassen JA, Wang PS, Dormuth C, Mogun H, Schneeweiss S. Evaluating the validity of an instrumental variable study of neuroleptics: can between-physician differences in prescribing patterns be used to estimate treatment effects? Med Care 2007; 45: S116-S122.
28. Schneeweiss S. Developments in post-marketing comparative effectiveness research. Clin Pharmacol Ther 2007; 82: 143-156. DOI:10.1038/sj.clpt.6100249
29. Linde K, Scholz M, Ramirez G, Clausius N, Melchart D, Jonas WB. Impact of study quality on outcome in placebo-controlled trials of homeopathy. J Clin Epidemiol 1999; 52: 631-636. DOI: 10.1016/S0895-4356(99)00048-7
30. Shang A, Huwiler-Müntener K, Nartey L, et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 2005; 366: 726-732. DOI: 10.1016/S0140-6736(05)67177-2
31. Dantas F, Rampes H. Do homeopathic medicines provoke adverse effects? A systematic review. Br Homeopath J 2000; 89: S35-S38.
32. Weiner DK, Ernst E. Complementary and alternative approaches to the treatment of persistent musculoskeletal pain. Clin J Pain 2004; 20: 244-255.
33. Lanas A. A review of the gastrointestinal safety data--a gastroenterologist's perspective. Rheumatology (Oxford) 2010; 49(Suppl 2): ii3-ii10. DOI: 10.1093/rheumatology/keq058
34. Kadam UT, Schellevis FG, Lewis M, et al. Does age modify the relationship between morbidity severity and physical health in English and Dutch family practice populations? Qual Life Res 2009; 18: 209-220. DOI: 10.1007/s11136-009-9442-x
35. Delaney JA, Biggs ML, Kronmal RA, Psaty BM. Demographic, medical, and behavioral characteristics associated with over the counter non-steroidal anti-inflammatory drug use in a population-based cohort: results from the Multi-Ethnic Study of Atherosclerosis. Pharmacoepidemiol Drug Saf 2011; 20: 83-89. DOI: 10.1002/pds.2065